查看購物車
  • English
  • Japanese
植入式心臟節律管理設備市場規模、佔有率和成長分析：按設備類型、應用、最終用戶和地區分類－2026-2033年產業預測
市場調查報告書
商品編碼
2053907

植入式心臟節律管理設備市場規模、佔有率和成長分析：按設備類型、應用、最終用戶和地區分類－2026-2033年產業預測

Implantable Cardiac Rhythm Management Device Market Size, Share, and Growth Analysis, By Device Type (Pacemakers, Implantable Cardioverter Defibrillators ), By Application, By End-User, By Region - Industry Forecast 2026-2033
出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2024 年全球植入式心臟節律管理設備市場價值為 225.2 億美元，預計到 2033 年將從 2025 年的 239.2 億美元成長至 388.5 億美元，預測期（2026-2033 年）的複合年成長率為 6.22%。

全球植入式心臟節律管理設備市場受人口老化以及心律不整和心臟衰竭衰竭盛行率不斷上升的驅動，凸顯了持續的臨床需求。該市場涵蓋從基礎型心律調節器到先進的植入式植入式心臟整流去顫器(ICD) 和心臟再同步治療系統等多種設備，旨在確保血流動力學穩定。在美敦力 (Medtronic) 和雅培 (Abbott) 等領先企業的Medtronic聯盟和收購推動下，該領域已從笨重的單腔裝置發展到配備先進 MRI 相容系統和整合診斷功能的無導線設備。未來的成長將由技術融合驅動，在改善臨床療效的同時降低醫療成本。此外，人工智慧 (AI) 透過持續的遠端評估、自動警報和個人化建議，正在變革患者監測和治療最佳化，最終簡化臨床醫生的工作流程，並擴大這些關鍵治療的覆蓋範圍。

全球植入式心臟節律管理設備市場的成長要素

全球植入式心臟節律管理設備市場的主要促進因素之一是心血管疾病盛行率的不斷上升，這使得有效的心臟節律管理解決方案變得尤為重要。隨著生活方式的改變和人口老化導致心臟相關疾病的增加，對能夠監測和調節心律的先進設備的需求也日益成長。小型化設備、遠端監測功能和更長的電池續航時間等技術創新進一步提升了植入式設備的吸引力。加之醫療專業人員和患者對這些技術的認知度和接受度不斷提高，這一趨勢正顯著推動市場成長。

全球植入式心臟節律管理設備市場的限制因素

全球植入式心臟節律管理設備市場的主要限制因素之一是這些設備及其植入手術的高成本。患者和醫療系統面臨的經濟負擔可能會限制他們獲得先進的心臟治療，尤其是在醫療基礎設施不完善的發展中地區。此外，各國的健保報銷政策差異顯著，導致這些醫療設備的保險保障範圍和支持力度不一致。這種不確定性可能會使醫療專業人員在推薦植入式設備時猶豫不決，從而影響市場成長和患者療效。監管障礙和複雜的供應鏈動態也進一步阻礙了市場擴張。

全球植入式心臟節律管理設備市場趨勢

全球植入式心臟節律管理裝置（ICR）市場正呈現出小型化和無導線技術的顯著趨勢，透過實現微創植入手術，徹底改變了患者照護方式。這項創新最大限度地降低了感染風險，提高了患者的舒適度，並使更多患者，尤其是體弱患者，能夠更方便地使用先進的心臟裝置。裝置製造商正致力於開發緊湊型設計、新型固定方法和節能電子元件，以最佳化裝置的性能和耐用性。這項轉變促進了醫療科技公司、專家和供應商之間的合作，同時也凸顯了生物相容性材料和簡化輸送系統的重要性，最終將推動裝置的普及，並活性化關鍵報銷問題的討論。

目錄

介紹

  • 調查目的
  • 市場定義和範圍

調查方法

  • 研究過程
  • 二級資料和一級資料的方法
  • 市場規模估算方法

執行摘要

  • 全球市場展望
  • 市場主要亮點
  • 細分市場概覽
  • 競爭環境概述

市場動態及展望

  • 總體經濟指標
  • 促進者和機會
  • 抑制因素和挑戰
  • 供給面趨勢
  • 需求面趨勢
  • 波特的分析和影響

關鍵市場分析

  • 關鍵成功因素
  • 影響市場的因素
  • 主要投資機會
  • 生態系測繪
  • 2025年市場魅力指數
  • PESTLE分析
  • 監理情勢

全球植入式心臟節律管理設備市場規模：依裝置類型分類

  • 心律調節器
    • 單人房
    • 雙腔體
    • 雙心室型（CRT-P）
  • 植入式心臟整流去顫器（ICD）
    • 單腔植入式心律轉復除顫器
    • 雙腔ICD
    • CRT-D
  • 皮下植入式心臟復律去顫器

全球植入式心臟節律管理設備市場規模：依應用領域分類。

  • 心搏過緩
  • 心搏過速
  • 心臟衰竭

全球植入式心臟節律管理設備市場規模：依最終用戶分類。

  • 醫院
  • 心臟中心

全球植入式心臟節律管理設備市場規模：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太國家
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲國家
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲國家

競爭資訊

  • 前五大公司對比
  • 主要公司2025年的市場定位
  • 主要市場公司採取的策略
  • 近期市場趨勢
  • 企業市場占有率分析，2025 年
  • 主要公司的完整公司簡介
    • 公司詳情
    • 產品系列分析
    • 按細分市場進行企業市佔率分析
    • 銷售收入年比比較（2023-2025 年）

主要公司簡介

  • Medtronic plc
  • Abbott Laboratories（St. Jude Medical）
  • Boston Scientific
  • Biotronik SE
  • LivaNova plc
  • MicroPort Scientific
  • Lepu Medical Technology
  • Oscor Inc.
  • Sorin Group（LivaNova）
  • Cardiac Science
  • ZOLL Medical（Asahi Kasei）
  • Cameron Health（Boston Scientific）
  • Imricor Medical Systems
  • EBR Systems
  • Nevro Corp.
  • Nalu Medical
  • Stimwave Technologies
  • Backbeat Medical
  • BioElectronics
  • AtaCor Medical

結論與建議

簡介目錄
Product Code: SQMIG35A3543

Global Implantable Cardiac Rhythm Management Device Market size was valued at USD 22.52 Billion in 2024 and is poised to grow from USD 23.92 Billion in 2025 to USD 38.85 Billion by 2033, growing at a CAGR of 6.22% during the forecast period (2026-2033).

The global implantable cardiac rhythm management device market is driven by an aging population coupled with the increasing prevalence of cardiac arrhythmias and heart failure, highlighting an ongoing clinical necessity. This market encompasses devices from basic pacemakers to advanced implantable cardioverter defibrillators and resynchronization systems that ensure hemodynamic stability. The sector has evolved significantly, transitioning from bulky single-chamber units to sophisticated MRI-compatible systems and leadless devices with in-built diagnostics, facilitated by strategic partnerships and acquisitions from major players like Medtronic and Abbott. The future growth is propelled by technological convergence, enhancing clinical outcomes while reducing care costs. Additionally, AI is transforming patient monitoring and therapy optimization through continuous remote assessment, automated alerts, and tailored recommendations, ultimately streamlining clinician workflows and expanding access to these vital therapies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Implantable Cardiac Rhythm Management Device market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Implantable Cardiac Rhythm Management Device Market Segments Analysis

Global implantable cardiac rhythm management device market is segmented by device type, application, end-user and region. Based on device type, the market is segmented into Pacemakers, Implantable Cardioverter Defibrillators (ICDs) and Subcutaneous ICD. Based on application, the market is segmented into Bradycardia, Tachycardia and Heart Failure. Based on end-user, the market is segmented into Hospitals and Cardiac Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Implantable Cardiac Rhythm Management Device Market

One of the key market drivers for the Global Implantable Cardiac Rhythm Management Device Market is the rising prevalence of cardiovascular diseases, which necessitates effective cardiac rhythm management solutions. As lifestyle changes and an aging population contribute to an increase in heart-related ailments, there is a growing demand for advanced devices that can monitor and regulate heart rhythms. Technological innovations, such as miniaturization of devices, remote monitoring capabilities, and improved battery life, further enhance the appeal of implantable devices. Combined with increasing awareness and acceptance of such technologies among healthcare providers and patients, this trend significantly propels market growth.

Restraints in the Global Implantable Cardiac Rhythm Management Device Market

One of the key market restraints for the Global Implantable Cardiac Rhythm Management Device Market is the high cost associated with these devices and their implantation procedures. The financial burden on patients and healthcare systems can limit access to advanced cardiac care, particularly in developing regions where healthcare infrastructure is less robust. Additionally, reimbursement policies vary significantly across countries, leading to inconsistencies in coverage and support for these medical devices. This uncertainty can deter healthcare providers from recommending implantable devices, thereby affecting market growth and patient outcomes. Regulatory hurdles and complex supply chain dynamics further complicate market expansion.

Market Trends of the Global Implantable Cardiac Rhythm Management Device Market

The Global Implantable Cardiac Rhythm Management Device market is witnessing a significant trend towards miniaturization and leadless technology, revolutionizing patient care by facilitating less invasive implantation techniques. This innovation minimizes infection risks and enhances patient comfort, making advanced cardiac devices more accessible to a broader range of patients, particularly those who are frailer. Device manufacturers are focused on developing compact designs, novel fixation strategies, and energy-efficient electronics to optimize performance and longevity. This shift encourages collaborative efforts among medical technology companies, specialists, and suppliers, while emphasizing biocompatible materials and simplified delivery systems, ultimately driving adoption and stimulating vital reimbursement discussions.

Table of Contents

Introduction

  • Objectives of the Study
  • Market Definition & Scope

Research Methodology

  • Research Process
  • Secondary & Primary Data Methods
  • Market Size Estimation Methods

Executive Summary

  • Global Market Outlook
  • Key Market Highlights
  • Segmental Overview
  • Competition Overview

Market Dynamics & Outlook

  • Macro-Economic Indicators
  • Drivers & Opportunities
  • Restraints & Challenges
  • Supply Side Trends
  • Demand Side Trends
  • Porters Analysis & Impact
    • Competitive Rivalry
    • Threat of Substitute
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factors
  • Market Impacting Factors
  • Top Investment Pockets
  • Ecosystem Mapping
  • Market Attractiveness Index 2025
  • PESTEL Analysis
  • Regulatory Landscape

Global Implantable Cardiac Rhythm Management Device Market Size by Device Type & CAGR (2026-2033)

  • Market Overview
  • Pacemakers
    • Single-Chamber
    • Dual-Chamber
    • Biventricular (CRT-P)
  • Implantable Cardioverter Defibrillators (ICDs)
    • Single-Chamber ICD
    • Dual-Chamber ICD
    • CRT-D
  • Subcutaneous ICD

Global Implantable Cardiac Rhythm Management Device Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Bradycardia
  • Tachycardia
  • Heart Failure

Global Implantable Cardiac Rhythm Management Device Market Size by End-User & CAGR (2026-2033)

  • Market Overview
  • Hospitals
  • Cardiac Centers

Global Implantable Cardiac Rhythm Management Device Market Size & CAGR (2026-2033)

  • North America (Device Type, Application, End-User)
    • US
    • Canada
  • Europe (Device Type, Application, End-User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Device Type, Application, End-User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Device Type, Application, End-User)
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Device Type, Application, End-User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Medtronic plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (St. Jude Medical)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biotronik SE
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LivaNova plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MicroPort Scientific
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lepu Medical Technology
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Oscor Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sorin Group (LivaNova)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardiac Science
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ZOLL Medical (Asahi Kasei)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cameron Health (Boston Scientific)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Imricor Medical Systems
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • EBR Systems
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nevro Corp.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nalu Medical
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stimwave Technologies
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Backbeat Medical
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioElectronics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AtaCor Medical
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations